Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2025-07-25 00:00:00 ET · period of report 2025-07-23 · accession 0001437749-25-023532 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-07-25 | 2025-07-23 | DMAC | JACINTO RICHARD II | 10% | P - Purchase | $3.50 | +400.0K | 4.96M | +9% | +$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Shares, no par value per share | 2025-07-23 | P | A | 400,000 | $3.50 | 4,958,823 | I By Roth IRA | — | — | (F1) These shares are held by NFS/FMTC Roth IRA FBO Richard Jacinto II, of which Richard Jacinto II is the beneficiary. |